Yayın:
Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?

dc.contributor.authorAydın, Ömer
dc.contributor.authorBüyükkaya, Ramazan
dc.contributor.buuauthorHakyemez, Bahattin
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentRadyoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-3425-0740
dc.contributor.researcheridAAI-2318-2021
dc.contributor.scopusid6602527239
dc.date.accessioned2023-01-30T11:39:48Z
dc.date.available2023-01-30T11:39:48Z
dc.date.issued2017-01-01
dc.description.abstractBackground Intracranial lesions exhibit clear contrast enhancement in T1-weighted imaging, but the mechanism whereby contrast-enhanced susceptibility-weighted imaging (CE-SWI) generates signals remains unclear. Contrast enhancement patterns cannot be reliably predicted. Purpose To explore the mechanism of CE-SWI contrast enhancement. Material and Methods Fifty-five patients were retrospectively enrolled. All of the imaging employed a clinical 3T magnetic resonance imaging (MRI) system fitted with a 32-channel head coil. Minimum-intensity projection reformatted images were evaluated. Intracranial lesions and brain parenchymal intensities were explored using SWI and CE-SWI. signal intensity rates were calculated by dividing the lesional intensity by the white matter intensity, after which the SWI and CE-SWI signal intensity rate were compared. Two observers independently performed intralesional susceptibility signal analysis. Results After contrast medium administration, malignant and extra-axial tumors exhibited obvious contrast enhancement on CE-SWI (P<0.001 and P=0.013, respectively). The signal intensity of white matter was significantly reduced. The signal intensity rates rose significantly in the benign, malignant, and extra-axial groups (P<0.001). Between-radiologist agreement in terms of intralesional susceptibility signal assessment was strong (kappa=0.8, P<0.001). Conclusion Contrast media can either reduce or increase SWI signal intensities. The dual contrast feature of CE-SWI can be useful when exploring intracranial disorders.
dc.identifier.citationAydın, Ö. vd. (2017). ''Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?''. Acta Radiologica, 58(1), 107-113.
dc.identifier.doi10.1177/0284185116637246
dc.identifier.endpage113
dc.identifier.issn0284-1851
dc.identifier.issue1
dc.identifier.pubmed26966145
dc.identifier.scopus2-s2.0-85006483742
dc.identifier.startpage107
dc.identifier.urihttps://doi.org/10.1177/0284185116637246
dc.identifier.uri1600-0455
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/0284185116637246
dc.identifier.urihttp://hdl.handle.net/11452/30713
dc.identifier.volume58
dc.identifier.wos000390557900015
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherSage Puplications
dc.relation.collaborationYurt içi
dc.relation.collaborationSanayi
dc.relation.journalActa Radiologica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRadiology, nuclear medicine & medical imaging
dc.subjectContrast medium
dc.subjectSusceptibility weighted imaging
dc.subjectBlood brain barrier
dc.subjectAngiogenesis
dc.subjectTumor
dc.subjectHigh-resolution
dc.subjectRadiation necrosis
dc.subjectGrade gliomas
dc.subjectBrain
dc.subjectDifferentiation
dc.subjectPatterns
dc.subjectMagnetic resonance imaging
dc.subjectTissue
dc.subjectTumors
dc.subjectAngiogenesis
dc.subjectBlood-brain barrier
dc.subjectContrast enhancement
dc.subjectContrast medium
dc.subjectContrast-enhanced
dc.subjectSignal intensities
dc.subjectSusceptibility weighted Imaging
dc.subjectWhite matter
dc.subjectContrast media
dc.subject.emtreeGadoterate meglumine
dc.subject.emtreeContrast medium
dc.subject.emtreeGadoterate meglumine
dc.subject.emtreeMeglumine
dc.subject.emtreeOrganometallic compound
dc.subject.emtreeAdolescent
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeBenign neoplasm
dc.subject.emtreeBrain cancer
dc.subject.emtreeBrain damage
dc.subject.emtreeBrain tissue
dc.subject.emtreeChild
dc.subject.emtreeContrast enhancement
dc.subject.emtreeControlled study
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeImage analysis
dc.subject.emtreeImage display
dc.subject.emtreeImage processing
dc.subject.emtreeIntermethod comparison
dc.subject.emtreeInterrater reliability
dc.subject.emtreeIntracranial tumor
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMale
dc.subject.emtreeNuclear magnetic resonance scanner
dc.subject.emtreeParenchyma
dc.subject.emtreePriority journal
dc.subject.emtreeRetrospective study
dc.subject.emtreeSignal detection
dc.subject.emtreeSusceptibility weighted imaging
dc.subject.emtreeWhite matter
dc.subject.emtreeAdult
dc.subject.emtreeBrain tumor
dc.subject.emtreeComplication
dc.subject.emtreeComputer assisted diagnosis
dc.subject.emtreeDiagnostic imaging
dc.subject.emtreeImage enhancement
dc.subject.emtreeMagnetic resonance angiography
dc.subject.emtreeMiddle aged
dc.subject.emtreeNeovascularization (pathology)
dc.subject.emtreePreschool child
dc.subject.emtreeProcedures
dc.subject.emtreeReproducibility
dc.subject.emtreeSensitivity and specificity
dc.subject.emtreeYoung adult
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBrain neoplasms
dc.subject.meshChild
dc.subject.meshChild, preschool
dc.subject.meshContrast media
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImage enhancement
dc.subject.meshImage interpretation, computer-assisted
dc.subject.meshMagnetic resonance angiography
dc.subject.meshMale
dc.subject.meshMeglumine
dc.subject.meshMiddle aged
dc.subject.meshNeovascularization, pathologic
dc.subject.meshOrganometallic compounds
dc.subject.meshReproducibility of results
dc.subject.meshSensitivity and specificity
dc.subject.meshYoung adult
dc.subject.scopusSubstantia Nigra; Susceptibility; Pulvinar
dc.subject.wosRadiology, nuclear medicine & medical imaging
dc.titleContrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Radyoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama